Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,604.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 1,851.00
  • 52 Week Low: 1,191.00
  • Currency: UK Pounds
  • Shares Issued: 208.75m
  • Volume: 28,818
  • Market Cap: £3,348.31m
  • RiskGrade: 125
  • Beta: 0.00

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 4.0% 0.0%
Div Cover 2.7 2.6
Op Mrgn 16.2% 20.6%
ROCE 17.5%  
Latest F'cast
P/E 9.2 9.2
PEG 5.2 1.0
Pr/Revenue 1.3 1.0
Pr/Book 1.7  
Latest F'cast
Revenue 7.1% -21.9%
PBT 14.1% 3.7%
EPS 1.8% -1.2%
DPS 5.0% -42.3%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 2,553.00 544.00 194.80¢ 15.1 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.3 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.6 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 11.8 n/a 0% 80.00¢ 3.0%
31-Dec-25 3,349.00 519.00 228.00¢ 9.0 4.5 +2% 84.00¢ 4.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 3,458.62 711.83 168.33p 9.5 n/a -1% 64.11p 0.0%
31-Dec-27 3,598.06 754.48 183.05p 8.7 1.0 +9% 67.92p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Hikma appoints Rebecca Hall as CFO 24-Sep-2026 07:00 RNS
Hikma R&D Investor Spotlight Series 22-Sep-2026 12:00 RNS
Director/PDMR Shareholding 22-Sep-2026 09:32 RNS

HIK ShareCast News

ViiV Healthcare's Rebecca Hall to join Hikma as ... 24-Sep-2026 ShareCast
Berenberg hikes target price on Hikma Pharmaceut... 11-Aug-2026 ShareCast
Hikma trades higher as strong branded growth dri... 06-Aug-2026 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 1,604.00p
Change Today 9.00p
% Change 0.56 %
52 Week High 1,851.00
52 Week Low 1,191.00
Volume 28,818
Shares Issued 208.75m
Market Cap £3,348.31m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income
38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 13-Aug-26 19-Mar-26
Paid 17-Sep-26 30-Apr-26
Amount 38.00¢ 48.00¢

Trades for 24-Sep-2026

Time Volume / Share Price
10:54 19 @ 1,604.00p
10:54 250 @ 1,604.00p
10:54 7 @ 1,604.00p
10:51 58 @ 1,605.00p
10:50 5 @ 1,604.00p

HIK Key Personnel

CEO Said Darwazah
Chair Victoria Hull

Top of Page